Diferencia entre revisiones de «Leptospirosis»

(added source)
Línea 28: Línea 28:


==Source==
==Source==
*Uptodate
#Palaniappan RU, Ramanujam S, Chang YF. Leptospirosis: pathogenesis, immunity, and diagnosis. Curr Opin Infect Dis. 2007;20(3):284-92
 
==See Also==
==See Also==
*[[Travel Medicine]]
*[[Travel Medicine]]

Revisión del 17:29 7 jun 2014

Background

  1. Human exposure from animal urine, contaminated water/soil, or infected animal tissue.
  2. Portal from break in skin, mucousa, or conjunctiva
  3. Average incubation of 10 days
Conjunctival suffusion

Clinical Manifestations

  1. fvr, myalgia, ha (75-100% of pts)
  2. conjuntival suffusion characteristic but not common
  3. meningitis, uveitis, transminitis, proteinuria, hematuria
  4. Weil syndrome-severe manifestation with jaundice and renal failure, pulmonary hemorrhage, ARDS, myocarditis, and rhabdomyolysis (52% Mortality)

Laboratory findings

  1. Confirm by serology
  2. Culture
  3. Hypokalemia/Hyponatremia
  4. Thrombocytopenia
  5. Sterile pyuria
  6. Elevated CK
  7. CSF with elevated wbcs and protein with normal glucose

Differential Diagnosis

Fever in traveler

Treatment

  1. Ceftriaxone, cefotaxime, PCN, azithromycin, or doxycycline
  2. Prefer azithro or doxy if unable to distinguish from rickettsial infection.
  3. Beware of Jarisch-Herxheimer reaction

Source

  1. Palaniappan RU, Ramanujam S, Chang YF. Leptospirosis: pathogenesis, immunity, and diagnosis. Curr Opin Infect Dis. 2007;20(3):284-92

See Also